| |
IBD
|
UC
|
CD
|
Healthy controls
|
|---|
| |
(n = 226)
|
(n = 189)
|
(n = 37)
|
(n = 290)
|
|---|
|
CMV detection
|
n (%)
|
n (%)
|
n (%)
|
n (%)
|
|
DNA DNA+
|
90 (84.07)a
|
161 (85.19)d
|
29 (78.38)g
|
173 (59.66)
|
|
Serum CMV IgG+
|
172 (76.11)b
|
139 (73.54)e
|
33 (89.19)h
|
147 (50.69)
|
|
Serum CMV IgM+
|
4 (1.77)c
|
3 (1.59)f
|
1 (2.70)i
|
1 (0.34)
|
- a Compare with healthy controls, OR = 3.569, 95% CI: 2.330-5.468, P < 0.001;
- b Compare with healthy controls, OR = 3.099, 95% CI: 2.113-4.543, P < 0.001;
- c Compare with healthy controls, OR = 5.207, 95% CI: 0.578-46.914, P = 0.235;
- d Compare with healthy controls, OR = 3.889, 95% CI:2.443-6.190, P < 0.001;
- e Compare with healthy controls, OR = 2.704, 95% CI:1.819-4.022, P < 0.001;
- f Compare with healthy controls, OR = 4.661, 95% CI:0.481-45.148, P = 0.344;
- g Compare with healthy controls, OR = 2.452, 95% CI:1.083-5.550, P = 0.027;
- h Compare with healthy controls, OR = 8.026, 95% CI:2.772-23.232, P < 0.001;
- i Compare with healthy controls, OR = 8.028, 95% CI:0.491-131.142, P = 0.540.
- IBD, inflammatory bowel disease; CMV, cytomegalovirus; UC, ulcerative colitis; CD, Crohn’s disease.
